Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Diabetes 62 (5), 15271536
This individualized approach means that two people at identical weights may have different treatment recommendations based on their age, metabolic profile, and existing medical conditions
2022 AHA/ACC/HFSA guideline for the management of heart failure: Executive summary: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines
And I think, you know, it goes back to so much in medicine is like Thyroid issues aren't a big deal